How much is the Anti-Obesity Drugs Market market?

The anti-obesity drugs market market size is estimated to grow at $$ 18330.1 mn in 2023. Read More

What is the growth rate of the Anti-Obesity Drugs Market market?

The growth rate of the anti-obesity drugs market year-over-year is 14.44%. Read More

Which region held the largest market share in the Anti-Obesity Drugs Market market?

North America is the region to held the largest market share with 66% growth. Read More

Who are the key players in the Anti-Obesity Drugs Market market?

Alvogen Iceland ehf, Amgen Inc., AstraZeneca Plc, Boehringer Ingelheim International GmbH, Eli Lilly and Co., Empros Pharma AB, ERX Pharmaceuticals Inc., Gelesis Inc., GlaxoSmithKline Plc, .... Read More

Which Segment has the largest market share in the Anti-Obesity Drugs Market market?

Type is the segment that has the largest market share in the market. Read More

Anti-obesity Drugs Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Canada, China - Size and Forecast 2024-2028

Published: May 2024
Pages: 166
SKU: IRTNTR70300

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

2.2 Market characteristics
- Market characteristics analysis

2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition

3.2 Market segment analysis
- Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Anti-Obesity Drugs Market 2018 - 2022
- Historic Market Size - Data Table on Global Anti-Obesity Drugs Market 2018 - 2022 ($ million)

4.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)

4.3 Drug Class segment analysis 2018 - 2022
- Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)

4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)

4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028

5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)

6.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type

6.3 Class III anti-obesity drugs - Market size and forecast 2023-2028
- Chart on Class III anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on Class III anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
- Chart on Class III anti-obesity drugs - Year-over-year growth 2023-2028 (%)
- Data Table on Class III anti-obesity drugs - Year-over-year growth 2023-2028 (%)

6.4 Class II anti-obesity drugs - Market size and forecast 2023-2028
- Chart on Class II anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on Class II anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
- Chart on Class II anti-obesity drugs - Year-over-year growth 2023-2028 (%)
- Data Table on Class II anti-obesity drugs - Year-over-year growth 2023-2028 (%)

6.5 Class I anti-obesity drugs - Market size and forecast 2023-2028
- Chart on Class I anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on Class I anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
- Chart on Class I anti-obesity drugs - Year-over-year growth 2023-2028 (%)
- Data Table on Class I anti-obesity drugs - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Drug Class

7.1 Market segments
- Chart on Drug Class - Market share 2023-2028 (%)
- Data Table on Drug Class - Market share 2023-2028 (%)

7.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class

7.3 Peripherally acting drugs - Market size and forecast 2023-2028
- Chart on Peripherally acting drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on Peripherally acting drugs - Market size and forecast 2023-2028 ($ million)
- Chart on Peripherally acting drugs - Year-over-year growth 2023-2028 (%)
- Data Table on Peripherally acting drugs - Year-over-year growth 2023-2028 (%)

7.4 Centrally acting drugs - Market size and forecast 2023-2028
- Chart on Centrally acting drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on Centrally acting drugs - Market size and forecast 2023-2028 ($ million)
- Chart on Centrally acting drugs - Year-over-year growth 2023-2028 (%)
- Data Table on Centrally acting drugs - Year-over-year growth 2023-2028 (%)

7.5 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)

9.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.11 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview

11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

11.3 Landscape disruption
- Overview on factors of disruption

11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered

12.2 Market positioning of companies
- Matrix on companies position and classification

12.3 Alvogen Iceland ehf
- Alvogen Iceland ehf - Overview
- Alvogen Iceland ehf - Product / Service
- Alvogen Iceland ehf - Key offerings

12.4 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings

12.5 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings

12.6 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings

12.7 Empros Pharma AB
- Empros Pharma AB - Overview
- Empros Pharma AB - Product / Service
- Empros Pharma AB - Key offerings

12.8 ERX Pharmaceuticals Inc.
- ERX Pharmaceuticals Inc. - Overview
- ERX Pharmaceuticals Inc. - Product / Service
- ERX Pharmaceuticals Inc. - Key offerings

12.9 Gelesis Inc.
- Gelesis Inc. - Overview
- Gelesis Inc. - Product / Service
- Gelesis Inc. - Key offerings

12.10 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus

12.11 Innovent Biologics Inc.
- Innovent Biologics Inc. - Overview
- Innovent Biologics Inc. - Product / Service
- Innovent Biologics Inc. - Key offerings

12.12 LG Chem Ltd.
- LG Chem Ltd. - Overview
- LG Chem Ltd. - Business segments
- LG Chem Ltd. - Key news
- LG Chem Ltd. - Key offerings
- LG Chem Ltd. - Segment focus

12.13 Novo Nordisk AS
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key news
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus

12.14 Rhythm Pharmaceuticals Inc.
- Rhythm Pharmaceuticals Inc. - Overview
- Rhythm Pharmaceuticals Inc. - Product / Service
- Rhythm Pharmaceuticals Inc. - Key news
- Rhythm Pharmaceuticals Inc. - Key offerings

12.15 SCOHIA PHARMA Inc.
- SCOHIA PHARMA Inc. - Overview
- SCOHIA PHARMA Inc. - Product / Service
- SCOHIA PHARMA Inc. - Key news
- SCOHIA PHARMA Inc. - Key offerings

12.16 VIVUS LLC
- VIVUS LLC - Overview
- VIVUS LLC - Product / Service
- VIVUS LLC - Key offerings

12.17 Zydus Lifesciences Ltd.
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus

13 Appendix